Team
The multidisciplinary and multisectoral Vax2Muc consortium brings together five universities, three research organisations and two SMEs with international renowned experts in:
mucosal immunity (TUM, TCD, SSI),
vaccine development (TUM, HZI, SSI),
process development and GMP production of proteins (SSI),
adjuvant R&D (SSI, HZI),
formulation R&D (UOS, FFUL, SSI, INSTAR),
preclinical validation in mice (TUM, HZI, SSI) and pigs (IRTA, SSI),
drug product GMP production (InStar),
clinical trials (UANTWERPEN),
vaccinology and immune monitoring (TUM, HZI, SSI, TCD, IRTA),
project management , dissemination and communication (LINQ)
Institute for Medical Microbiology, Immunology and Hygiene,
TUM School of Medicine and Health
Department Preclinical Medicine, Technical University of Munich (TUM)
Germany
Prof. Dr. Markus Gerhard, MD, PhD
Principal Investigator and Coordinator of the Project
Email
Dr. Verena Friedrich, PhD
Scientific Project Manager and Scientist
Email
